前收市價 | 5.21 |
開市 | 5.13 |
買盤 | 0.00 x 0 |
賣出價 | 0.00 x 0 |
今日波幅 | 5.04 - 5.27 |
52 週波幅 | 2.19 - 5.91 |
成交量 | |
平均成交量 | 921,729 |
市值 | 3.722B |
Beta 值 (5 年,每月) | 1.60 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -0.32 |
業績公佈日 | 2024年5月09日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 5.50 |
Cannabis stocks could see higher highs. All thanks to recent legalization in Germany, the addition of a cannabis vote in Florida, growing approval ratings in polls, and speculation it could be favorably mentioned in the election. According to the Pew Research Center, about nine in 10 Americans (88%) said that cannabis should be legal for medical or recreational use. About 57% said cannabis should be legal for both medical and recreational use. About 32% said it should just be legal for medical u
If you’re looking for Wall Street’s favorite cannabis stocks, you’re most likely to find them amongst the holdings of the AdvisorShares Pure US Cannabis ETF (NYSEARCA:MSOS), the largest U.S.-listed cannabis exchange traded fund (ETF). MSOS is an actively managed ETF with just under $1 billion in net assets. Its net assets are more than four times those of the next largest fund, Amplify Alternative Harvest ETF (NYSEARCA:MJ), with $243 million in net assets. If you’ve held MSOS since its launch in
As excitement builds, U.S. federal agencies are looking to revise cannabis regulations. Support for cannabis legalization has surged to unprecedented levels, which bodes incredibly well for cannabis stocks. A Gallup survey in November last year revealed that a staggering 70% of Americans advocate for cannabis legalization, marking a historic high in public sentiment. This sentiment is further underscored by the wave of states legalizing cannabis for both recreational and medical purposes, along